Do I need a prescription for Glycine powder?

Glycine powder is classified as a Valid as a prescribable product in the UK. However, always consult a pharmacist or doctor before use. (Source: NHS dm+d)

What are the brand names for Glycine powder?

Glycine powder is the generic name. It is available under brand names including: Glycine powder, Glycine powder. (Source: NHS dm+d — Actual Medicinal Products)

Glycine powder

Prescription only

Requires a prescription from a doctor or prescriber

Powder

Other

A non-essential amino acid.

Active ingredients:

Glycine

Formulation:

Gluten-free

Does not contain gluten — suitable for coeliac disease

BNF classificationBrowse formulary

Where this medicine sits in the British National Formulary — the UK's standard prescribing reference

BNF 09.11.01

Chemical classBrowse classes

Classification based on the molecule's chemical structure and properties

Check interactions for Glycine

No active safety alerts

Official documents, adverse reaction reporting, and safety monitoring

Report a side effect

Submit a Yellow Card report to the MHRA

Official medicine documents

Yellow Card

Report side effects (MHRA)

Drug safety updates

MHRA alerts for Glycine

Source: MHRA Products DatabaseOGL 3.0

Updated 3 months ago(16 Jan 2026)

Safety monitoring data

Yellow Card reports

MHRA

The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.

View Drug Analysis Profile

Suspected adverse reactions reported for Glycine

Browse all iDAP reports

Interactive Drug Analysis Profiles for all medicines

Report a side effect

Submit a Yellow Card report to the MHRA

Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.

EudraVigilance

EMA

The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.

View EudraVigilance report

Suspected adverse reactions reported for Glycine

About EudraVigilance

Learn about EU pharmacovigilance and safety monitoring

EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.

2 branded products available

2 productsShow details

2 products

Possibly available on the UK marketRestricted supplyDiscontinuedAvailability per NHS dm+d

MHRA licensed products

View all licensed products for Glycine on the MHRA register

Glycine powder

Nutricia Ltd

None

Glycine powder

Special Order

None

Special

Source: NHS dm+dOGL 3.0

Updated about 1 month ago(1 Mar 2026)

Therapeutically similar medicines

10 similarShow details

Generic Vivomixx drops

Other

Same BNF section

Generic HealthAid Colonease Plus capsules

Capsule

Same BNF section

Arginine 500mg/5ml oral solution sugar free

Oral solution

500mg/5ml

Same BNF section

Ubidecarenone 25mg/5ml oral solution sugar free

Oral solution

25mg/5ml

Same BNF section

Ubidecarenone 50mg/5ml oral solution sugar free

Oral solution

50mg/5ml

Same BNF section

Similarity based on WHO Anatomical Therapeutic Chemical (ATC) classification and NHS BNF section grouping. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.

NHS prescribing volume and spending trends

Show details

Loading prescribing data...

Clinical guidelines and formulary information

British National Formulary

Glycine

BNF

Drug monograph — bnf.nice.org.uk

Source: British National Formulary, NICE. Joint Formulary Committee. Contains public sector information licensed under the Open Government Licence v3.0.

NICE clinical guidance(2)

The PLASMA system for transurethral resection and haemostasis of the prostate (HTG563)

HTG563

Guidance

Updated Jan 2021

PLASMA system with button electrode for electrovaporisation of the prostate (MIB274)

MIB274

Guidance

Updated Aug 2021

Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.

Check stock at pharmacies and supply information

Show details

Pharmacy stock checkers

Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.

Boots

Search products

Click & collectNHS

Lloyds

Search products

DeliveryNHS

P2U

Pharmacy2U

Search products

DeliveryNHS

Supply & product information

Official product databases and supply status monitoring

Shortages info

NHS Specialist Pharmacy Service (SPS)

emc product search

Discontinuations & alternatives for Glycine

Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. emc (electronic medicines compendium) is operated by Datapharm Ltd. Shortage information sourced from NHS Specialist Pharmacy Service (SPS), sps.nhs.uk.

Codes for healthcare professionals and prescribing systems

Show details

These codes are used by healthcare IT systems and prescribers to identify this medicine.

NHS UK identifiers

SNOMED CT

17631811000001103

dm+d ID

17631811000001103

VTM (Virtual Therapeutic Moiety)

776135005

VMP (Virtual Medicinal Product)

17631811000001103

BNF code

09110100

SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF codes from NHS Business Services Authority (NHSBSA).

Active and completed clinical studies from ClinicalTrials.gov

Show details

Searching UK clinical trials...

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.

Pharmacology and chemical data from DrugBank

go.drugbank.com

Key facts

Drug status

Approved

Major interactions

None known

Half-life

Not available

Mechanism

In the CNS, there exist strychnine-sensitive glycine binding sites as well as st…

Food interactions

None known

Human targets

25 targets

Data: DrugBank · CC BY-NC 4.0

Pharmacokinetics at a glance

Absorption

Absorbed from the small intestine via an active transport mechanism.

Metabolism

Hepatic

Pharmacokinetic data: DrugBank · CC BY-NC 4.0

Status:

Approved

Investigational

Nutraceutical

Vet approved

Small molecule

About this compound

A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.

Properties:

solid

Avg. mass: 75.07 Da

DrugBank indication

Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.

Also known as(160)

Aminoacetic acid

Aminoessigsäure

Aminoethanoic acid

Glicina

Gly

Glycin

Glycine

Glycocoll

Dosage forms(61)

Solution (Parenteral)

Powder (Topical)

Solution (Intravenous) — 10.50 g/1000ml

Injection (Intravenous) — 0.5 g/l

Injection (Intravenous) — 0.25 g/1000ml

Solution, concentrate (Intravenous)

Injection (Intravenous) — 0.52 g/l

Liquid (Intravenous)

Molecular properties(19)

Drug interactions(8)

Known interactions with other medications. Always consult a healthcare professional.

Digoxin

Unknown severity

DB00390

The risk or severity of adverse effects can be increased when Glycine is combined with Digoxin.

Check this interaction

Acetyldigitoxin

Unknown severity

DB00511

The risk or severity of adverse effects can be increased when Glycine is combined with Acetyldigitoxin.

Check this interaction

Deslanoside

Unknown severity

DB01078

The risk or severity of adverse effects can be increased when Glycine is combined with Deslanoside.

Check this interaction

Digitoxin

Unknown severity

DB01396

The risk or severity of adverse effects can be increased when Glycine is combined with Digitoxin.

Check this interaction

Metildigoxin

Unknown severity

DB13401

The risk or severity of adverse effects can be increased when Glycine is combined with Metildigoxin.

Check this interaction

Lanatoside C

Unknown severity

DB13467

The risk or severity of adverse effects can be increased when Glycine is combined with Lanatoside C.

Check this interaction

Gitoformate

Unknown severity

DB13537

The risk or severity of adverse effects can be increased when Glycine is combined with Gitoformate.

Check this interaction

Acetyldigoxin

Unknown severity

DB13691

The risk or severity of adverse effects can be increased when Glycine is combined with Acetyldigoxin.

Check this interaction

Showing 8 of 8 interactions

Toxicity & overdose

ORL-RAT LD₅₀ 7930 mg/kg, SCU-RAT LD₅₀ 5200 mg/kg, IVN-RAT LD₅₀ 2600 mg/kg, ORL-MUS LD₅₀ 4920 mg/kg; Doses of 1 gram daily are very well tolerated. Mild gastrointestinal symptoms are infrequently noted. In one study doses of 90 grams daily were also well tole.

How it works

Mechanism of action

In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS.

Pharmacodynamics

Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system.

Pharmacokinetics

How the body processes this drug — absorption, distribution, metabolism, and elimination

Absorption

Absorbed from the small intestine via an active transport mechanism.

Metabolism

Hepatic

Drug targets(25)

Proteins and enzymes this drug interacts with in the body

Glutamate receptor ionotropic, NMDA 2A

BE0000760

GRIN2A

antagonist

Specific functionamyloid-beta binding

Cellular location

Cell projection, dendritic spine

General function & pharmacology

Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) .
PMID:20890276 PMID:23933818 PMID:23933819 PMID:23933820 PMID:24504326 PMID:26875626 PMID:26919761 PMID:28242877 PMID:36117210 PMID:38538865 PMID:8768735

NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the slow phase of excitatory postsynaptic current, long-term synaptic potentiation, and learning (By similarity). Channel activation requires binding of the neurotransmitter L-glutamate to the GluN2 subunit, glycine or D-serine binding to the GluN1 subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) .
PMID:23933818 PMID:23933819 PMID:23933820 PMID:24504326 PMID:26875626 PMID:26919761 PMID:27288002 PMID:28095420 PMID:28105280 PMID:28126851 PMID:28182669 PMID:29644724 PMID:38307912 PMID:8768735

NMDARs mediate simultaneously the potasium efflux and the influx of calcium and sodium (By similarity). Each GluN2 subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, Ca2(+) permeability, and binding to allosteric modulators .
PMID:26875626 PMID:26919761
Participates in the synaptic plasticity regulation through activation by the L-glutamate releaseed by BEST1, into the synaptic cleft, upon F2R/PAR-1 activation in astrocyte (By similarity)

2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial

BE0000518

GCAT

substrate

Specific functionglycine C-acetyltransferase activity

Cellular location

Mitochondrion

General function & pharmacology

Pyridoxal phosphate (PLP) dependent enzyme, which catalyzes the cleavage of 2-amino-3-oxobutanoate to glycine and acetyl-CoA

5-aminolevulinate synthase, non-specific, mitochondrial

BE0000409

ALAS1

substrate

Specific function5-aminolevulinate synthase activity

Cellular location

Mitochondrion inner membrane

General function & pharmacology

Catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation of succinyl-CoA and glycine to form aminolevulinic acid (ALA), with CoA and CO2 as by-products

5-aminolevulinate synthase, erythroid-specific, mitochondrial

BE0000898

ALAS2

substrate

Specific function5-aminolevulinate synthase activity

Cellular location

Mitochondrion inner membrane

General function & pharmacology

Catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation of succinyl-CoA and glycine to form aminolevulinic acid (ALA), with CoA and CO2 as by-products .
PMID:14643893 PMID:21252495 PMID:21309041 PMID:21653323 PMID:32499479 PMID:34492704

Contributes significantly to heme formation during erythropoiesis PMID:2050125

Glycine--tRNA ligase

BE0000998

GARS1

substrate

Specific functionATP binding

Cellular location

Cytoplasm

General function & pharmacology

Catalyzes the ATP-dependent ligation of glycine to the 3'-end of its cognate tRNA, via the formation of an aminoacyl-adenylate intermediate (Gly-AMP) .
PMID:17544401 PMID:24898252 PMID:28675565

Also produces diadenosine tetraphosphate (Ap4A), a universal pleiotropic signaling molecule needed for cell regulation pathways, by direct condensation of 2 ATPs. Thereby, may play a special role in Ap4A homeostasis PMID:19710017

Metabolizing enzymes(4)

Enzymes involved in drug metabolism — important for understanding drug interactions

Enzyme activity key

substrate

inhibitor

inducer

AMTAminomethyltransferase, mitochondrial

substrate

GLDCGlycine dehydrogenase (decarboxylating), mitochondrial

substrate

DLDDihydrolipoyl dehydrogenase, mitochondrial

substrate

GCSHGlycine cleavage system H protein, mitochondrial

substrate

Transporters(5)

Proteins that transport this drug across cell membranes

Monocarboxylate transporter 10

BE0003654

SLC16A10

substrate

inhibitor

Specific functionamino acid transmembrane transporter activity

Cellular location

Cell membrane

General function & pharmacology

Sodium- and proton-independent thyroid hormones and aromatic acids transporter .
PMID:11827462 PMID:18337592 PMID:28754537

Mediates both uptake and efflux of 3,5,3'-triiodothyronine (T3) and 3,5,3',5'-tetraiodothyronine (T4) with high affinity, suggesting a role in the homeostasis of thyroid hormone levels .
PMID:18337592
Responsible for low affinity bidirectional transport of the aromatic amino acids, such as phenylalanine, tyrosine, tryptophan and L-3,4-dihydroxyphenylalanine (L-dopa) .
PMID:11827462 PMID:28754537
Plays an important role in homeostasis of aromatic amino acids (By similarity)

Proton-coupled amino acid transporter 1

BE0000536

SLC36A1

substrate

Specific functionABC-type taurine transporter transporter activity

Cellular location

Cell membrane

General function & pharmacology

Electrogenic proton/amino acid symporter with selectivity for small apolar L-amino acids, their D-enantiomers and selected amino acid derivatives such as 4-aminobutanoate/GABA .
PMID:12527723 PMID:12809675 PMID:19549785

May be involved in the efflux from the lysosomal compartment of neutral amino acids resulting from proteolysis (By similarity). May play a role in specifying sites for exocytosis in neurons (By similarity)

Vesicular inhibitory amino acid transporter

BE0002308

SLC32A1

substrate

Specific functionamino acid transmembrane transporter activity

Cellular location

Cytoplasmic vesicle membrane

General function & pharmacology

Antiporter that exchanges vesicular protons for cytosolic 4-aminobutanoate or to a lesser extend glycine, thus allowing their secretion from nerve terminals. The transport is equally dependent on the chemical and electrical components of the proton gradient (By similarity). May also transport beta-alanine (By similarity).

Acidification of GABAergic synaptic vesicles is a prerequisite for 4-aminobutanoate uptake (By similarity)

Sodium- and chloride-dependent glycine transporter 2

BE0002310

SLC6A5

substrate

Specific functionglycine

Cellular location

Cell membrane

General function & pharmacology

Sodium- and chloride-dependent glycine transporter .
PMID:10381548 PMID:10606742 PMID:16751771 PMID:31370103 PMID:9845349

Terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals .
PMID:9845349
May be responsible for the termination of neurotransmission at strychnine-sensitive glycinergic synapses PMID:9845349

Sodium- and chloride-dependent glycine transporter 1

BE0000940

SLC6A9

substrate

Specific functionamino acid

Cellular location

Cell membrane

General function & pharmacology

Sodium- and chloride-dependent glycine transporter .
PMID:8183239
Essential for regulating glycine concentrations at inhibitory glycinergic synapses

Biological pathways(76)

Glutathione Metabolism

metabolic

Involved compounds

ATP,Flavin adenine dinucleotide,gamma-Glutamylcysteine,Glutathione,Glycine,Alanine,Cysteine,Glutamic acid,Pidolic acid,S-Methyl glutathione,Zinc

Porphyrin Metabolism

metabolic

Involved compounds

Aminolevulinic acid,Coproporphyrinogen III,Farnesyl diphosphate,Flavin adenine dinucleotide,Glycine,Iron,Mesoheme,NADH,Protoporphyrin,Pyridoxal phosphate,Uridine-5'-Diphosphate,Zinc

Bile Acid Biosynthesis

metabolic

Involved compounds

Deoxycholic acid,Taurine,ATP,Chenodeoxycholic acid,Cholesterol,Cholic Acid,Pyrophosphoric acid,Flavin adenine dinucleotide,Glycine,Iron,Mesoheme,NADH,Palmitic Acid,Taurochenodeoxycholic acid,Taurocholic acid

Alanine Metabolism

metabolic

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Biotin,Pyrophosphoric acid,Glycine,Glyoxylic acid,Alanine,Glutamic acid,Pyridoxal phosphate,Pyruvic acid,Zinc

5-Oxoprolinuria

disease

Involved compounds

ATP,Flavin adenine dinucleotide,gamma-Glutamylcysteine,Glutathione,Glycine,Alanine,Cysteine,Glutamic acid,Pidolic acid,S-Methyl glutathione,Zinc

gamma-Glutamyltransferase Deficiency

disease

Involved compounds

ATP,Flavin adenine dinucleotide,gamma-Glutamylcysteine,Glutathione,Glycine,Alanine,Cysteine,Glutamic acid,Pidolic acid,S-Methyl glutathione,Zinc

Lactic Acidemia

disease

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Biotin,Pyrophosphoric acid,Glycine,Glyoxylic acid,Alanine,Glutamic acid,Pyridoxal phosphate,Pyruvic acid,Zinc

Congenital Bile Acid Synthesis Defect Type II

disease

Involved compounds

Cerebrotendinous Xanthomatosis (CTX)

disease

Involved compounds

Zellweger Syndrome

disease

Involved compounds

Familial Hypercholanemia (FHCA)

disease

Involved compounds

Congenital Bile Acid Synthesis Defect Type III

disease

Involved compounds

Glutathione Synthetase Deficiency

disease

Involved compounds

ATP,Flavin adenine dinucleotide,gamma-Glutamylcysteine,Glutathione,Glycine,Alanine,Cysteine,Glutamic acid,Pidolic acid,S-Methyl glutathione,Zinc

Hereditary Coproporphyria (HCP)

disease

Involved compounds

Aminolevulinic acid,Coproporphyrinogen III,Farnesyl diphosphate,Flavin adenine dinucleotide,Glycine,Iron,Mesoheme,NADH,Protoporphyrin,Pyridoxal phosphate,Uridine-5'-Diphosphate,Zinc

Acute Intermittent Porphyria

disease

Involved compounds

Aminolevulinic acid,Coproporphyrinogen III,Farnesyl diphosphate,Flavin adenine dinucleotide,Glycine,Iron,Mesoheme,NADH,Protoporphyrin,Pyridoxal phosphate,Uridine-5'-Diphosphate,Zinc

Congenital Erythropoietic Porphyria (CEP) or Gunther Disease

disease

Involved compounds

Aminolevulinic acid,Coproporphyrinogen III,Farnesyl diphosphate,Flavin adenine dinucleotide,Glycine,Iron,Mesoheme,NADH,Protoporphyrin,Pyridoxal phosphate,Uridine-5'-Diphosphate,Zinc

Porphyria Variegata (PV)

disease

Involved compounds

Aminolevulinic acid,Coproporphyrinogen III,Farnesyl diphosphate,Flavin adenine dinucleotide,Glycine,Iron,Mesoheme,NADH,Protoporphyrin,Pyridoxal phosphate,Uridine-5'-Diphosphate,Zinc

Pyruvate Carboxylase Deficiency

disease

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Biotin,Pyrophosphoric acid,Glycine,Glyoxylic acid,Alanine,Glutamic acid,Pyridoxal phosphate,Pyruvic acid,Zinc

Primary Hyperoxaluria Type I

disease

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Biotin,Pyrophosphoric acid,Glycine,Glyoxylic acid,Alanine,Glutamic acid,Pyridoxal phosphate,Pyruvic acid,Zinc

Carnitine Synthesis

metabolic

Involved compounds

Oxogluric acid,Glycine,Iron,Levocarnitine,Lysine,NADH,Pyridoxal phosphate,Ademetionine,Succinic acid,Ascorbic acid

5-Oxoprolinase Deficiency

disease

Involved compounds

ATP,Flavin adenine dinucleotide,gamma-Glutamylcysteine,Glutathione,Glycine,Alanine,Cysteine,Glutamic acid,Pidolic acid,S-Methyl glutathione,Zinc

gamma-Glutamyltranspeptidase Deficiency

disease

Involved compounds

ATP,Flavin adenine dinucleotide,gamma-Glutamylcysteine,Glutathione,Glycine,Alanine,Cysteine,Glutamic acid,Pidolic acid,S-Methyl glutathione,Zinc

27-Hydroxylase Deficiency

disease

Involved compounds

Sarcosine Oncometabolite Pathway

disease

Involved compounds

Betaine aldehyde,ATP,Choline,N,N-dimethylglycine,Pyrophosphoric acid,Flavin adenine dinucleotide,Glycine,Methionine,Serine,Magnesium cation,NADH,Potassium cation,Pyridoxal phosphate,Ademetionine,Tetrahydrofolic acid,Zinc

ATC classification(1 code)

ATC B05CX03

Affected organisms(1)

Humans and other mammals

International brands(1)

Experimental properties(4)

External resources(1)

PDRhealth

Commercial products(248)

Chemical identifiers

CAS, UNII, InChI Key and database cross-references

Show

Linked compound data from DrugBank Open Data (CC BY-NC 4.0)

Glycine

DB00145

CAS number

56-40-6

UNII (FDA)

TE7660XO1C

InChI Key (molecular fingerprint)

DHMQDGOQFOQNFH-UHFFFAOYSA-N

Additional database identifiers

Drugs Product Database (DPD)

8865

ChEBI

57305

PubChem Compound

750

PubChem Substance

46508219

KEGG Compound

C00037

KEGG Drug

D00011

ChemSpider

730

BindingDB

18133

PharmGKB

PA449789

PDB

GLY

Therapeutic Targets Database

DAP000288

IUPHAR

727

Guide to Pharmacology

727

Wikipedia

Glycine

ChEMBL

CHEMBL773

ZINC

ZINC000004658552

RxCUI

4919

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4585

GenAtlas

GRIN2A

GeneCards

GRIN2A

GenBank Gene Database

U09002

GenBank Protein Database

558749

IUPHAR

456

Guide to Pharmacology

456

UniProtKB

Q12879

UniProt Accession

NMDE1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4188

GenAtlas

GCAT

GeneCards

GCAT

GenBank Gene Database

AF077740

GenBank Protein Database

3342906

UniProtKB

O75600

UniProt Accession

KBL_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:396

GenAtlas

ALAS1

GeneCards

ALAS1

GenBank Gene Database

X56351

GenBank Protein Database

28583

UniProtKB

P13196

UniProt Accession

HEM1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:397

GenAtlas

ALAS2

GeneCards

ALAS2

GenBank Gene Database

X56352

GenBank Protein Database

28586

UniProtKB

P22557

UniProt Accession

HEM0_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4162

GenAtlas

GARS

GeneCards

GARS1

GenBank Gene Database

D30658

GenBank Protein Database

1311463

UniProtKB

P41250

UniProt Accession

GARS_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:932

GenAtlas

BAAT

GeneCards

BAAT

GenBank Gene Database

L34081

GenBank Protein Database

532505

UniProtKB

Q14032

UniProt Accession

BAAT_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4472

GenAtlas

GPR18

GeneCards

GPR18

GenBank Gene Database

L42324

GenBank Protein Database

1066731

IUPHAR

Guide to Pharmacology

UniProtKB

Q14330

UniProt Accession

GPR18_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4624

GenAtlas

GSS

GeneCards

GSS

GenBank Gene Database

L42531

GenBank Protein Database

886284

UniProtKB

P48637

UniProt Accession

GSHB_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4587

GenAtlas

GRIN2C

GeneCards

GRIN2C

GenBank Gene Database

L76224

GenBank Protein Database

1196449

IUPHAR

458

Guide to Pharmacology

458

UniProtKB

Q14957

UniProt Accession

NMDE3_HUMAN

GenBank Gene Database

AK223555

GenBank Protein Database

62898842

UniProtKB

Q53ET4

UniProt Accession

Q53ET4_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:13734

GenAtlas

GLYAT

GeneCards

GLYAT

GenBank Gene Database

AF023466

GenBank Protein Database

2554941

UniProtKB

Q6IB77

UniProt Accession

GLYAT_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:10852

GenAtlas

SHMT2

GeneCards

SHMT2

GenBank Gene Database

U23143

GenBank Protein Database

746436

UniProtKB

P34897

UniProt Accession

GLYM_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:24178

GenAtlas

GLYATL2

GeneCards

GLYATL2

GenBank Gene Database

AF426250

GenBank Protein Database

29243559

UniProtKB

Q8WU03

UniProt Accession

GLYL2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:30519

GenAtlas

GLYATL1

GeneCards

GLYATL1

GenBank Gene Database

DQ084381

GenBank Protein Database

71384826

UniProtKB

Q969I3

UniProt Accession

GLYL1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:14412

GenAtlas

AGXT2

GeneCards

AGXT2

GenBank Gene Database

AJ292204

GenBank Protein Database

12406973

UniProtKB

Q9BYV1

UniProt Accession

AGT2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:17804

GenAtlas

PIPOX

GeneCards

PIPOX

GenBank Gene Database

AF134593

GenBank Protein Database

7157903

UniProtKB

Q9P0Z9

UniProt Accession

SOX_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:16768

GenAtlas

GRIN3B

GeneCards

GRIN3B

GenBank Gene Database

AC004528

GenBank Protein Database

3025446

IUPHAR

461

UniProtKB

O60391

UniProt Accession

NMD3B_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4326

GenAtlas

GLRA1

GeneCards

GLRA1

GenBank Gene Database

X52009

GenBank Protein Database

31851

IUPHAR

423

Guide to Pharmacology

423

UniProtKB

P23415

UniProt Accession

GLRA1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:341

GenAtlas

AGXT

GeneCards

AGXT

GenBank Gene Database

X56092

GenBank Protein Database

36582

UniProtKB

P21549

UniProt Accession

AGT1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4329

GenAtlas

GLRB

GeneCards

GLRB

GenBank Gene Database

U33267

GenBank Protein Database

992687

IUPHAR

427

Guide to Pharmacology

427

UniProtKB

P48167

UniProt Accession

GLRB_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:10850

GenAtlas

SHMT1

GeneCards

SHMT1

GenBank Gene Database

L11931

GenBank Protein Database

307422

UniProtKB

P34896

UniProt Accession

GLYC_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4328

GenAtlas

GLRA3

GeneCards

GLRA3

GenBank Gene Database

AF017724

GenBank Protein Database

3342792

IUPHAR

425

Guide to Pharmacology

425

UniProtKB

O75311

UniProt Accession

GLRA3_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4327

GenAtlas

GLRA2

GeneCards

GLRA2

GenBank Gene Database

X52008

GenBank Protein Database

31849

IUPHAR

424

Guide to Pharmacology

424

UniProtKB

P23416

UniProt Accession

GLRA2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4415

GenAtlas

GNMT

GeneCards

GNMT

GenBank Gene Database

AF101477

GenBank Protein Database

8671584

UniProtKB

Q14749

UniProt Accession

GNMT_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4175

GenAtlas

GATM

GeneCards

GATM

GenBank Gene Database

S68805

GenBank Protein Database

545385

UniProtKB

P50440

UniProt Accession

GATM_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:473

GenAtlas

AMT

GeneCards

AMT

GenBank Gene Database

D13811

GenBank Protein Database

391721

UniProtKB

P48728

UniProt Accession

GCST_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4313

GenAtlas

GLDC

GeneCards

GLDC

GenBank Gene Database

M63635

GenBank Protein Database

190287

UniProtKB

P23378

UniProt Accession

GCSP_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2898

GenAtlas

DLD

GeneCards

DLD

GenBank Gene Database

J03490

GenBank Protein Database

307137

UniProtKB

P09622

UniProt Accession

DLDH_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:4208

GenAtlas

GCSH

GeneCards

GCSH

GenBank Gene Database

M69175

GenBank Protein Database

184348

UniProtKB

P23434

UniProt Accession

GCSH_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:17027

GeneCards

SLC16A10

GenBank Gene Database

AB057445

GenBank Protein Database

18640047

UniProtKB

Q8TF71

UniProt Accession

MOT10_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:18761

GenAtlas

SLC36A1

GeneCards

SLC36A1

GenBank Gene Database

AF516142

GenBank Protein Database

31324239

Guide to Pharmacology

1161

UniProtKB

Q7Z2H8

UniProt Accession

S36A1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:11018

GenAtlas

SLC32A1

GeneCards

SLC32A1

GenBank Gene Database

AY044836

GenBank Protein Database

17975777

Guide to Pharmacology

1133

UniProtKB

Q9H598

UniProt Accession

VIAAT_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:11051

GenAtlas

SLC6A5

GeneCards

SLC6A5

GenBank Gene Database

AF085412

GenBank Protein Database

4003525

Guide to Pharmacology

936

UniProtKB

Q9Y345

UniProt Accession

SC6A5_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:11056

GenAtlas

SLC6A9

GeneCards

SLC6A9

GenBank Gene Database

S70609

GenBank Protein Database

546769

Guide to Pharmacology

935

UniProtKB

P48067

UniProt Accession

SC6A9_HUMAN

International reference pricing

4 formulations

Reference pricing from DrugBank. Prices are indicative and may not reflect current UK costs.

From $0.02/ml

To $0.31/ml

Glycine 1.5% irrigation

$0.02/ml

Amino acetic acid powder

$0.03/g

Glycine powder

$0.03/g

Diluent for flolan vial

$0.31/ml

Source: DrugBank. Used under CC BY-NC 4.0 academic licence for non-commercial purposes.

Patent information

1 active patent

12390398

United States

Approved 3 May 2016 · Expires 3 May 2036

10y 1m

Source: DrugBank · CC BY-NC 4.0. Patent data sourced from national patent offices. Expiry dates may not reflect extensions, regulatory exclusivity periods, or legal challenges.

DrugBank citations

If you use DrugBank data in your research, please cite the following publications:

Knox C., Wilson M., Klinger C.M., et al

DrugBank 6.

0: the DrugBank Knowledgebase for 2024

Nucleic Acids Res. 2024 Jan 552(D1):D1265-D1275

PMID: 37953279

Wishart D.S., Feunang Y.D., Guo A.C., et al

DrugBank 5.

0: a major update to the DrugBank database for 2018

Nucleic Acids Res. 2017 Nov 846(D1):D1074-D1082

PMID: 29126136

Show earlier publications

Law V., Knox C., Djoumbou Y., et al

DrugBank 4.

0: shedding new light on drug metabolism

Nucleic Acids Res. 2014 Jan 142(1):D1091-7

PMID: 24203711

Knox C., Law V., Jewison T., et al

DrugBank 3.

0: a comprehensive resource for 'omics' research on drugs

Nucleic Acids Res. 2011 Jan39(Database issue):D1035-41

PMID: 21059682

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a knowledgebase for drugs, drug actions and drug targets.

Nucleic Acids Research

2008 Jan36(Database issue):D901-6

PMID: 18048412

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a comprehensive resource for in silico drug discovery and exploration.

Nucleic Acids Research

2006 Jan 134(Database issue):D668-72

PMID: 16381955

Source: go.drugbank.comCC BY-NC 4.0

Updated about 1 month ago(4 Mar 2026)

Back to medicines

Glycine powder

Official medicine documents

Safety monitoring data

Yellow Card reports

EudraVigilance

British National Formulary

NICE clinical guidance(2)

Pharmacy stock checkers

Supply & product information

NHS UK identifiers

Key facts

Pharmacokinetics at a glance

Absorption

Metabolism

Clinical essentials

Pharmacology

Deep science
110

Chemical identifiers

Glycine

Additional database identifiers

International reference pricing

Patent information

DrugBank citations

Glycine powder

Safety & regulatory

Official medicine documents

Safety monitoring data

Yellow Card reports

EudraVigilance

Brand versions and licensed products

Medicines like this

Prescribing statistics

Guidance (NICE / BNF)

British National Formulary

NICE clinical guidance(2)

Availability, stocks & shortages

Pharmacy stock checkers

Supply & product information

Professional identifiers

NHS UK identifiers

Clinical trials

DrugBank data

Key facts

Pharmacokinetics at a glance

Absorption

Metabolism

Clinical essentials

Pharmacology

Deep science110

Chemical identifiers

Glycine

Additional database identifiers

International reference pricing

Patent information

DrugBank citations

Deep science
110